<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0208851.ref022">
 <label>22</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Kam</surname>
   <given-names>YW</given-names>
  </name>, 
  <name>
   <surname>Lee</surname>
   <given-names>WW</given-names>
  </name>, 
  <name>
   <surname>Simarmata</surname>
   <given-names>D</given-names>
  </name>, 
  <name>
   <surname>Harjanto</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Teng</surname>
   <given-names>TS</given-names>
  </name>, 
  <name>
   <surname>Tolou</surname>
   <given-names>H</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Longitudinal analysis of the human antibody response to Chikungunya virus infection: implications for serodiagnosis and vaccine development</article-title>. 
  <source>Journal of virology</source>. 
  <year>2012</year>;
  <volume>86</volume>(
  <issue>23</issue>):
  <fpage>13005</fpage>â€“
  <lpage>15</lpage>. 
  <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.01780-12" xmlns:xlink="http://www.w3.org/1999/xlink">10.1128/JVI.01780-12</ext-link> ; PubMed Central PMCID: PMC3497641.
  <?supplied-pmid 23015702?>
  <pub-id pub-id-type="pmid">23015702</pub-id>
 </mixed-citation>
</ref>
